Primary pulmonary nuclear protein of the testis midline carcinoma: case report and systematic review with pooled analysis

Bibliographic Details
Title: Primary pulmonary nuclear protein of the testis midline carcinoma: case report and systematic review with pooled analysis
Authors: Dong Zhao, Wei Cao, Shiqian Zha, Yixuan Wang, Zhou Pan, Jingyi Zhang, Ke Hu
Source: Frontiers in Oncology, Vol 13 (2024)
Publisher Information: Frontiers Media S.A., 2024.
Publication Year: 2024
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: pulmonary, NUT midline carcinoma (NMC), survival, pleural effusion, nuclear protein of the testis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Nuclear protein of the testis (NUT) midline carcinoma (NMC) is a rare tumor, with particularly low incidence in the lungs, and a correspondingly poor prognosis. To determine the clinicopathological characteristics, outcomes, and prognostic factors of primary pulmonary NMC, a case was reported and a systematic review was performed. Twenty-nine records, including ours, involving 62 cases, were finally included. The median age at diagnosis was 29.5 years. At presentation, the most common symptoms at presentation were cough (47.50%) and chest/back pain (37.50%). In terms of diagnosis, 32.14% of NMC cases were identified through immunohistochemistry (IHC); However, a greater number of cases may be misdiagnosed initially, and ultimately, the diagnosis of NMC was confirmed through a combination of IHC and fluorescence in situ hybridization (FISH). Despite the clinical application of various chemotherapy-based treatments, the actual effectiveness remains unsatisfactory. Furthermore, Cox regression analysis of multiple factors identified male gender and concurrent presence of pleural effusion as indicators of shorter survival time in patients. These results emphasize the importance of increased diagnostic awareness among clinical and pathology practitioners concerning NMC. While there is currently no established standard for treating NMC, a treatment approach combining multiple methods shows promise for future research. Concurrently, clinical and foundational investigations addressing variables such as gender and the presence of pleural effusion may yield valuable insights into the diagnosis and treatment of NMC.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2234-943X
Relation: https://www.frontiersin.org/articles/10.3389/fonc.2023.1308432/full; https://doaj.org/toc/2234-943X
DOI: 10.3389/fonc.2023.1308432
Access URL: https://doaj.org/article/bf5a29a9d4dc451b9c588e7e60034bf2
Accession Number: edsdoj.bf5a29a9d4dc451b9c588e7e60034bf2
Database: Directory of Open Access Journals
More Details
ISSN:2234943X
DOI:10.3389/fonc.2023.1308432
Published in:Frontiers in Oncology
Language:English